301 related articles for article (PubMed ID: 20337499)
1. Noninvasive urinary metabonomic diagnosis of human bladder cancer.
Pasikanti KK; Esuvaranathan K; Ho PC; Mahendran R; Kamaraj R; Wu QH; Chiong E; Chan EC
J Proteome Res; 2010 Jun; 9(6):2988-95. PubMed ID: 20337499
[TBL] [Abstract][Full Text] [Related]
2. Urinary metabotyping of bladder cancer using two-dimensional gas chromatography time-of-flight mass spectrometry.
Pasikanti KK; Esuvaranathan K; Hong Y; Ho PC; Mahendran R; Raman Nee Mani L; Chiong E; Chan EC
J Proteome Res; 2013 Sep; 12(9):3865-73. PubMed ID: 23885889
[TBL] [Abstract][Full Text] [Related]
3. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
4. Low- and high-grade bladder cancer determination via human serum-based metabolomics approach.
Bansal N; Gupta A; Mitash N; Shakya PS; Mandhani A; Mahdi AA; Sankhwar SN; Mandal SK
J Proteome Res; 2013 Dec; 12(12):5839-50. PubMed ID: 24219689
[TBL] [Abstract][Full Text] [Related]
5. Distinct urinary metabolic profile of human colorectal cancer.
Cheng Y; Xie G; Chen T; Qiu Y; Zou X; Zheng M; Tan B; Feng B; Dong T; He P; Zhao L; Zhao A; Xu LX; Zhang Y; Jia W
J Proteome Res; 2012 Feb; 11(2):1354-63. PubMed ID: 22148915
[TBL] [Abstract][Full Text] [Related]
6. Urinary metabonomic study on colorectal cancer.
Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
[TBL] [Abstract][Full Text] [Related]
7. Metabolic signatures of lung cancer in biofluids: NMR-based metabonomics of urine.
Carrola J; Rocha CM; Barros AS; Gil AM; Goodfellow BJ; Carreira IM; Bernardo J; Gomes A; Sousa V; Carvalho L; Duarte IF
J Proteome Res; 2011 Jan; 10(1):221-30. PubMed ID: 21058631
[TBL] [Abstract][Full Text] [Related]
8. Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry.
Issaq HJ; Nativ O; Waybright T; Luke B; Veenstra TD; Issaq EJ; Kravstov A; Mullerad M
J Urol; 2008 Jun; 179(6):2422-6. PubMed ID: 18433783
[TBL] [Abstract][Full Text] [Related]
9. Serum and urinary metabonomic study of human osteosarcoma.
Zhang Z; Qiu Y; Hua Y; Wang Y; Chen T; Zhao A; Chi Y; Pan L; Hu S; Li J; Yang C; Li G; Sun W; Cai Z; Jia W
J Proteome Res; 2010 Sep; 9(9):4861-8. PubMed ID: 20690664
[TBL] [Abstract][Full Text] [Related]
10. LC-MS-based serum metabolic profiling for genitourinary cancer classification and cancer type-specific biomarker discovery.
Lin L; Huang Z; Gao Y; Chen Y; Hang W; Xing J; Yan X
Proteomics; 2012 Aug; 12(14):2238-46. PubMed ID: 22685041
[TBL] [Abstract][Full Text] [Related]
11. The simultaneous use of telomerase, cytokeratin 20 and CD4 for bladder cancer detection in urine.
Siracusano S; Niccolini B; Knez R; Tiberio A; Benedetti E; Bonin S; Ciciliato S; Pappagallo GL; Belgrano E; Stanta G
Eur Urol; 2005 Mar; 47(3):327-33. PubMed ID: 15716196
[TBL] [Abstract][Full Text] [Related]
12. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
[TBL] [Abstract][Full Text] [Related]
14. Global gas chromatography/time-of-flight mass spectrometry (GC/TOFMS)-based metabonomic profiling of lyophilized human feces.
Phua LC; Koh PK; Cheah PY; Ho HK; Chan EC
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Oct; 937():103-13. PubMed ID: 24029555
[TBL] [Abstract][Full Text] [Related]
15. Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry.
Wu H; Xue R; Dong L; Liu T; Deng C; Zeng H; Shen X
Anal Chim Acta; 2009 Aug; 648(1):98-104. PubMed ID: 19616694
[TBL] [Abstract][Full Text] [Related]
16. Gas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasis.
Li ZF; Wang J; Huang C; Zhang S; Yang J; Jiang A; Zhou R; Pan D
Rapid Commun Mass Spectrom; 2010 Sep; 24(18):2765-75. PubMed ID: 20814984
[TBL] [Abstract][Full Text] [Related]
17. Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
Zhou Y; Song R; Ma C; Zhou L; Liu X; Yin P; Zhang Z; Sun Y; Xu C; Lu X; Xu G
Oncotarget; 2017 Mar; 8(13):20719-20728. PubMed ID: 28157703
[TBL] [Abstract][Full Text] [Related]
18. RRLC-MS/MS-based metabonomics combined with in-depth analysis of metabolic correlation network: finding potential biomarkers for breast cancer.
Chen Y; Zhang R; Song Y; He J; Sun J; Bai J; An Z; Dong L; Zhan Q; Abliz Z
Analyst; 2009 Oct; 134(10):2003-11. PubMed ID: 19768207
[TBL] [Abstract][Full Text] [Related]
19. Bladder cancer determination via two urinary metabolites: a biomarker pattern approach.
Huang Z; Lin L; Gao Y; Chen Y; Yan X; Xing J; Hang W
Mol Cell Proteomics; 2011 Oct; 10(10):M111.007922. PubMed ID: 21799048
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry.
Wu H; Xue R; Lu C; Deng C; Liu T; Zeng H; Wang Q; Shen X
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):3111-7. PubMed ID: 19716777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]